Piccoleto II: my interview during JIM 2020 on the 1 year outcome of the Piccoleto II study


1. What was the PICCOLETO II study design and what did it aim to assess?
2. What are the key outcomes and how do they compare to studies such as BASKET-SMALL II?
3. Were there limitations with PICCOLETO II?
4. In your opinion, how should PICCOLETO II influence practice?
5. What questions remain unanswered that require further research?

Sirolimus: my interview during JIM 2020 on the current status of research concerning Sirolimus-coated balloons for coronary use


1. Why are Sirolimus DCBs needed as a technology?
2. How does the Sirolimus coating work?
3. What data supports there use in comparison to other DCBs?
4. When are you using DCBs in your practice?
5. What further research is required to validate sirolimus DCBs as the coating of choice?